- A retrospective study presents outcomes of intensity-modulated radiotherapy (IMRT) in elderly patients with nasopharyngeal carcinoma (NPC) and suggests that concurrent chemoradiotherapy (CCRT) does not improve survival.
Why this matters
- The benefits of IMRT and CCRT in elderly patients with NPC are unclear.
- 3.5% of patients experienced grade 4 acute leukopenia, 3.5% experienced grade 4 acute neutropenia, and 2.0% experienced grade 4 acute thrombocytopenia; there were no grade 4 late toxicities.
- Charlson comorbidity index (HR, 0.176; P=.007) was associated with 5-year locoregional recurrence-free survival (LRRFS) in multivariate analysis.
- T and N stage were associated with 5-year distant metastasis-free survival (DMFS; HR, 1.538 [P=.036] and 1.794 [P=.005], respectively), disease-specific survival (DSS; HR, 1.552 [P=.021] and 1.854 [P=.009], respectively), and OS (HR, 1.571 [P=.001] and 1.622 [P=.001], respectively) in multivariate analysis.
- Patients who received RT alone vs CCRT had similar LRRFS (94.0% vs 92.2%; P=.463), DMFS (83.5% vs 86.2%; P=.278), DSS (81.8% vs 83.1%; P=.384), and OS (74.0% vs 72.8%; P=.542).
- 254 patients aged ≥60 years with nonmetastatic NPC who underwent IMRT were analyzed for outcomes.
- Funding: Science and Technology Project of Guangdong Province; Wu Jieping Medical Foundation.
- Retrospective study.